Literature DB >> 7843807

Reversibility of tachyphylaxis to C5A in guinea pig tissues, perfused human placental lobule, and umbilical artery.

S M Taylor1, A M Finch, A E Heron, L C Brown, T H Florin.   

Abstract

The spasmogenic effect of C5a is mediated by histamine and/or eicosanoids. Tachyphylaxis to this effect of C5a occurs rapidly, but the spasmogenic effects of C5a on a guinea pig lung parenchymal strips, field-stimulated ventricular papillary muscle, and human umbilical artery were completely restored by a 1-h period of drug-free rest, whereas that of guinea pig ileum was not. Perfusion of the isolated human placental lobule with C5a caused a transient pressor response that was largely abolished by indomethacin (5 microM), indicating mediation by cyclooxygenase metabolites. This pressor response to C5a was also completely restored following a 1-h rest period. The results show that tissue rest reverses tachyphylaxis to the spasmogenic effects of C5a in tissues where the response is mediated by cyclooxygenase metabolites. Where the response is mediated by histamine released by mast cells, restoration does not occur, presumably because of the catastrophic nature of mast cell degranulation. Histamine released in guinea pig papillary muscle by C5a may be from non-mast-cell sources.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843807     DOI: 10.1007/bf01535262

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  21 in total

1.  Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states.

Authors:  S J Siciliano; T E Rollins; M S Springer
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

2.  Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.

Authors:  F Marceau; D deBlois; C Laplante; E Petitclerc; G Pelletier; J H Grose; T E Hugli
Journal:  Circ Res       Date:  1990-11       Impact factor: 17.367

3.  Biologic activity of synthetic analogues of C5a anaphylatoxin.

Authors:  J A Ember; S D Sanderson; S M Taylor; M Kawahara; T E Hugli
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

4.  Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.

Authors:  C Gerard; T E Hugli
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

5.  Markers of physical integrity and metabolic viability of the perfused human placental lobule.

Authors:  G R Cannell; R M Kluck; S E Hamilton; R H Mortimer; W D Hooper; R G Dickinson
Journal:  Clin Exp Pharmacol Physiol       Date:  1988-11       Impact factor: 2.557

6.  Synthetic C5a receptor agonists. Pharmacology, metabolism and in vivo cardiovascular and hematologic effects.

Authors:  G Drapeau; S Brochu; D Godin; L Levesque; F Rioux; F Marceau
Journal:  Biochem Pharmacol       Date:  1993-03-24       Impact factor: 5.858

7.  Contraction of the guinea-pig ileum induced by anaphylatoxin independent of histamine release.

Authors:  G Bodammer; W Vogt
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

8.  Cardiac dysfunction caused by recombinant human C5A anaphylatoxin: mediation by histamine, adenosine and cyclooxygenase arachidonate metabolites.

Authors:  U del Balzo; I Sakuma; R Levi
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

9.  Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.

Authors:  D E Van Epps; S Simpson; J G Bender; D E Chenoweth
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

10.  Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.

Authors:  N P Stimler-Gerard; S J Galli
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

View more
  2 in total

1.  Pharmacological characterization of antagonists of the C5a receptor.

Authors:  N J Paczkowski; A M Finch; J B Whitmore; A J Short; A K Wong; P N Monk; S A Cain; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.

Authors:  A J Short; N J Paczkowski; S M Vogen; S D Sanderson; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.